| Market Cap | 6.33B | P/E | 12.92 | EPS this Y | - | Ern Qtrly Grth | -74.10% |
| Income | 50.67B | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
| Sales | 1.11T | PEG | - | EPS past 5Y | - | 200D Avg Chg | -3.00% |
| Dividend | 782.00% | Price/Book | 0.01 | EPS next 5Y | - | 52W High Chg | -20.00% |
| Recommedations | - | Quick Ratio | 0.96 | Shares Outstanding | 558.21M | 52W Low Chg | 16.00% |
| Insider Own | - | ROA | 4.50% | Shares Float | 278.58M | Beta | 0.03 |
| Inst Own | - | ROE | 6.98% | Shares Shorted/Prior | -/- | Price | 11.50 |
| Gross Margin | 29.61% | Profit Margin | 4.58% | Avg. Volume | 519 | Target Price | - |
| Oper. Margin | 5.36% | Earnings Date | Aug 6 | Volume | 162 | Change | -0.13% |
Meiji Holdings Co., Ltd., through its subsidiaries, engages in the manufacture and sale of dairy products, confectioneries, nutritional products, and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceutical. It provides yogurt, cheese, drinking milk, beverages, butter, margarine, cream, ice cream, frozen food, chocolates, gummy, chewing gums, sports nutrition products, protein, infant formula, enteral formula, beauty supplements, OTC drugs, feed stuffs, sugar, and corn sweeteners. The company also offers ethical pharmaceutical products, including drugs for infectious and CNC disorders, vaccines, blood plasma products, generic drugs, and animal health products. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.